NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 936 filers reported holding NOVARTIS A G in Q1 2015. The put-call ratio across all filers is 0.51 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $4,491,000 | -27.1% | 55,545 | -24.3% | 1.41% | -22.5% |
| Q4 2017 | $6,160,000 | -2.2% | 73,370 | -0.0% | 1.82% | -6.7% |
| Q3 2017 | $6,300,000 | +3.3% | 73,385 | +0.4% | 1.96% | +9.2% |
| Q2 2017 | $6,100,000 | +136.9% | 73,080 | +110.8% | 1.79% | +104.9% |
| Q1 2017 | $2,575,000 | +3.1% | 34,670 | +1.1% | 0.87% | +2.7% |
| Q4 2016 | $2,498,000 | -8.5% | 34,290 | -0.8% | 0.85% | -10.3% |
| Q3 2016 | $2,729,000 | -11.8% | 34,565 | -7.8% | 0.95% | -14.0% |
| Q2 2016 | $3,094,000 | -14.8% | 37,500 | -4.3% | 1.10% | -15.8% |
| Q4 2014 | $3,632,000 | -18.5% | 39,199 | -17.3% | 1.31% | -21.4% |
| Q3 2014 | $4,459,000 | -4.5% | 47,374 | -8.1% | 1.67% | -1.9% |
| Q2 2014 | $4,667,000 | +3.9% | 51,555 | -2.5% | 1.70% | +0.6% |
| Q1 2014 | $4,493,000 | +1.1% | 52,850 | -4.4% | 1.69% | +4.2% |
| Q4 2013 | $4,444,000 | -23.0% | 55,285 | -26.5% | 1.62% | -26.8% |
| Q3 2013 | $5,772,000 | +7.8% | 75,245 | -0.6% | 2.21% | +3.0% |
| Q2 2013 | $5,353,000 | – | 75,706 | – | 2.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
| PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
| MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
| Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
| BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
| SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
| PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
| Elefante Mark B | 5,619 | $417,000 | 3.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
| CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |